The regenerative medicine segment, in particular, is capturing a larger market share due to increased approvals for clinical trials on stem cell therapies targeting various diseases​​.
Additionally, the global market for stem cell technologies and therapies is projected to grow at an annual rate (CAGR) of 11.43% from 2024 to 2030, with a focus on regenerative medicine and drug discovery and development. The regenerative medicine segment, in particular, is capturing a larger market share due to increased approvals for clinical trials on stem cell therapies targeting various diseases​​.